Initial Treatment for Supraventricular Tachycardia (SVT)
Begin with vagal maneuvers immediately in all hemodynamically stable patients, followed by IV adenosine if vagal maneuvers fail; proceed directly to synchronized cardioversion in any hemodynamically unstable patient. 1, 2, 3
Step 1: Assess Hemodynamic Stability First
Your immediate decision point is whether the patient is hemodynamically stable or unstable. 3
Hemodynamically unstable is defined by the presence of:
- Hypotension
- Altered mental status
- Signs of shock
- Chest pain suggesting acute ischemia
- Acute heart failure 3
If ANY of these signs are present, skip all other interventions and proceed immediately to synchronized cardioversion at 50-100J. 2, 3 Do not waste time with vagal maneuvers or medications—every second counts. 3
Step 2: For Hemodynamically Stable Patients - Vagal Maneuvers
The modified Valsalva maneuver is your first-line intervention (Class I, Level B evidence). 1, 2
Modified Valsalva Technique (Most Effective):
- Patient bears down against a closed glottis for 10-30 seconds while supine (generating 30-40 mm Hg intrathoracic pressure) 1, 2
- Immediately after the strain phase, lay the patient flat and elevate their legs 2
- This modified technique is 2.8-3.8 times more effective than standard Valsalva, with success rates of 27.7-43% 3, 4
Alternative Vagal Maneuvers (if modified Valsalva unavailable):
- Carotid sinus massage: Apply steady pressure over right or left carotid sinus for 5-10 seconds after confirming absence of bruit 1
- Ice-cold wet towel to face (diving reflex) 1
Critical pitfall: Never apply pressure to the eyeball—this is dangerous and abandoned. 1
Step 3: If Vagal Maneuvers Fail - Adenosine
Adenosine 6 mg rapid IV bolus is your next intervention (Class I, Level B evidence). 1, 2, 3
Adenosine Administration Protocol:
- Give as rapid IV push through a large peripheral vein 3
- Immediately follow with 20 mL saline flush 3
- If no response after 1-2 minutes, give 12 mg rapid IV bolus 3
- If still no response, may give one additional 12 mg dose 3
- Success rate: 90-95% for AVNRT and orthodromic AVRT 1, 2, 3
Critical Dosing Adjustments:
- Reduce to 3 mg for patients taking dipyridamole, carbamazepine, or with transplanted heart 2
- Larger doses may be needed with theophylline, caffeine, or theobromine 2
Absolute Contraindications to Adenosine:
- Asthma or bronchospastic lung disease (can cause severe bronchoconstriction) 2, 5
- Second- or third-degree AV block without pacemaker 5
- Sick sinus syndrome without pacemaker 5
- Known hypersensitivity to adenosine 5
Safety Requirements:
- Have electrical cardioversion equipment immediately available when administering adenosine 1, 2
- Adenosine may precipitate atrial fibrillation that can conduct rapidly and even cause ventricular fibrillation 1
- Appropriate resuscitative measures must be available 5
Step 4: If Adenosine Fails - Alternative Pharmacologic Therapy
For hemodynamically stable patients who fail adenosine:
IV diltiazem or verapamil (Class IIa, Level B evidence) 1
- Effective in 80-98% of cases 1
IV beta blockers are reasonable alternatives (Class IIa, Level C evidence) 1
Critical Safety Warning:
Never give verapamil, diltiazem, or beta blockers if:
- Wide-complex tachycardia (QRS ≥120 ms) of uncertain etiology 2, 3
- Known accessory pathway or pre-excitation on baseline ECG 1, 2
- Systolic heart failure 2
These agents can precipitate ventricular fibrillation or hemodynamic collapse in these scenarios. 1, 2
Step 5: If Pharmacologic Therapy Fails - Synchronized Cardioversion
Synchronized cardioversion is recommended when pharmacological therapy is ineffective or contraindicated (Class I, Level B evidence). 1, 2
- Perform after adequate sedation/anesthesia in stable patients 1, 2
- Start with 50-100J biphasic energy 3
- Increase stepwise if initial shock fails 3
- Success rate approaches 100% 1
Special Case: Pre-Excited Atrial Fibrillation (Irregular Wide-Complex)
If you suspect pre-excited AF (irregular wide-complex tachycardia in patient with known WPW):
Unstable: Immediate synchronized cardioversion 1, 3
Stable: IV ibutilide or procainamide 1, 3
NEVER give adenosine, verapamil, diltiazem, or beta blockers—these can accelerate ventricular rate and cause ventricular fibrillation. 3
Post-Conversion Management
- Patients often have atrial or ventricular premature complexes immediately after conversion that may reinitiate tachycardia 1
- An antiarrhythmic drug may be required to prevent acute reinitiation 1, 3
- Arrange cardiology follow-up for consideration of catheter ablation, which has 94.3-98.5% single-procedure success rate 3